id: melatonin_supplementation_to_pap_adherence
name: Melatonin Supplementation (10mg) â†’ PAP Therapy Adherence
from_node:
  node_id: melatonin_supplementation
  node_name: Melatonin Supplementation (10mg)
to_node:
  node_id: pap_adherence
  node_name: PAP Therapy Adherence
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Melatonin reduces insomnia symptoms and nighttime awakenings'
- 'Step 2: Improved sleep quality reduces discomfort and intolerance associated with
  PAP use'
- 'Step 3: Better sleep experience while using PAP increases motivation for continued
  use'
- 'Step 4: PAP device usage duration overnight increases reflecting improved adherence'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Tahereh Madani Motlaq et al. 2024. "Effect of melatonin on insomnia
    and daytime sleepiness, in patients with obstructive sleep apnea and insomnia
    (COMISA): A randomized double-blinded placebo-controlled trial." *Journal of Pharmaceutical
    Health Care and Sciences*. https://doi.org/10.1186/s40780-024-00347-9'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.024517'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: insomnia_severity_reduction
  direction: strengthens
  strength: strong
  description: PAP adherence improvement likely mediated through reduction in insomnia
    symptoms that contribute to PAP intolerance
